QHealth – Quantum Innovation in Pharmacogenomics

From 2020 to 2023, Gloin took part in QHealth, an ambitious R&D initiative focused on quantum pharmacogenomics. The mission was clear: improve quality of life and longevity in the aging population by applying quantum computing to the optimization of drug treatments.

QHealth explored how a patient’s genetic and physiological profile influences their response to medication. By combining hybrid classical and quantum computing models, the project delivered a system capable of simulating complex drug interactions—a level of analysis previously unattainable with traditional technologies.

The initiative brought together leading research institutions including the Extremadura University Institute for Biosanitary Research (INUBE), the University of Castilla-La Mancha (UCLM), and the University of Extremadura (UNEX), alongside technology partners such as Alhambra IT, Madrija, and Gloin.

🎯 The Challenge

An aging population and the widespread use of multiple medications among older adults present a critical healthcare challenge:

• Prevent adverse drug reactions driven by genetic and physiological factors.

• Optimize pharmacological treatments to enhance patient outcomes.

• Reduce healthcare costs associated with side effects and ineffective therapies.

• Overcome the computational limits of traditional simulation models, which struggle to process large-scale data within practical timeframes.

The healthcare system needs smarter, more predictive tools — not incremental improvements.

🚀 The Solution

Gloin contributed its expertise in advanced software engineering and high-performance systems to help design a pioneering methodological and technological framework.

We co-developed a hybrid classical/quantum platform capable of:

• Running pharmacological interaction simulations beyond the reach of classical computing alone.

• Processing genetic and pharmacological data to predict individual patient responses.

• Integrating with healthcare applications so medical professionals can leverage predictive insights in treatment planning.

Our role extended beyond technical execution. We actively participated in applied research, contributing to knowledge generation in one of the most cutting-edge fields in modern healthcare: quantum pharmacogenomics.

🔧 Technology

QHealth leveraged the combined power of quantum computing and machine learning algorithms, delivering tangible advantages:

• Ultra-fast pharmacological simulations, previously impossible with conventional systems.

• Accurate prediction of adverse effects, increasing medication safety.

• Optimization of personalized treatments, tailoring drug selection and dosage to each patient.

• Healthcare cost reduction, minimizing ineffective treatments and avoidable complications.

This technological model lays the foundation for next-generation healthcare solutions that integrate pharmacogenomics, artificial intelligence, and quantum computing — enabling more precise, personalized, and efficient medicine.

💊 Results & Impact

Through close collaboration between research, technology, and healthcare teams, QHealth achieved:

• The development of a methodological and technological framework for applying quantum computing in pharmacogenomics.

• The creation of scientific optimization models for treatment design, with transformative potential for personalized medicine.

• Strengthened international research collaboration, supported by leading scientific institutions.

• The groundwork for future patents and advanced developments in quantum computing applied to healthcare.

QHealth has also received recognition and support from national and international scientific bodies, reinforcing its position at the forefront of quantum-driven pharmacogenomics innovation.